Scientists have discovered a population of cells that begin the process of programmed cell death, survive it, and rapidly rebuild damaged tissue, with their descendants becoming far more resistant to future damage. This mechanism could offer a powerful route to improving tissue healing after injury, but it carries a darker implication too: the same resilience that helps healthy tissue recover may also help cancer cells survive treatment and return, making the discovery as significant for oncology as it is for regenerative medicine.
Read more at ScienceDaily